Skye Bioscience, Inc. Quarterly Interest Expense in USD from Q4 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Skye Bioscience, Inc. quarterly/annual Interest Expense history and growth rate from Q4 2012 to Q1 2024.
  • Skye Bioscience, Inc. Interest Expense for the quarter ending March 31, 2024 was $437K, a 2275% increase year-over-year.
  • Skye Bioscience, Inc. Interest Expense for the twelve months ending March 31, 2024 was $1.32M, a 173% increase year-over-year.
  • Skye Bioscience, Inc. annual Interest Expense for 2023 was $906K, a 36.3% increase from 2022.
  • Skye Bioscience, Inc. annual Interest Expense for 2022 was $665K, a 13.5% decline from 2021.
  • Skye Bioscience, Inc. annual Interest Expense for 2021 was $769K, a 8.89% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.32M $437K +$419K +2275% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $906K $430K +$381K +768% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $526K $271K +$60.1K +28.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $466K $186K -$18.9K -9.19% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $484K $18.4K -$181K -90.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $665K $49.6K -$149K -75.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $814K $211K +$15.9K +8.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $799K $205K +$15.2K +8.02% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $783K $199K +$14.1K +7.64% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $769K $199K +$13K +7.02% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $756K $195K +$12.7K +6.98% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $743K $190K +$18.4K +10.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $725K $185K +$18.6K +11.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $706K $186K -$103K -35.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $810K $183K -$119K -39.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $929K $172K -$122K -41.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $1.05M $166K +$50.3K +43.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1M $289K +$232K +407% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $769K $302K +$302K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $467K $294K +$294K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $173K $116K +$78.4K +208% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $94.8K $57.1K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $37.7K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q2 2014 -$211K $776 +$114 +17.2% May 1, 2014 Jul 31, 2014 10-Q 2014-09-15
Q1 2014 -$211K $307* -$342 Jan 31, 2014 Apr 30, 2014 10-Q 2014-06-05
Q4 2013 -$210K $410 -$213K -99.8% Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $2.15K -$212K Aug 1, 2013 Oct 31, 2013 10-K 2014-01-27
Q2 2013 $662 May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $649 Jan 31, 2013 Apr 30, 2013 10-Q 2014-06-05
Q4 2012 $213K Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.